Grifols is a global healthcare company founded in Barcelona in 1909 committed to improving the health and well-being of people around the world. The company develops, produces and provides innovative healthcare services and solutions in more than 110 countries. A pioneer in the plasma industry, Grifols develops innovative plasma-derived medicines and other biopharmaceutical solutions that treat patients with chronic, rare and, at times, life-threatening conditions.
With a workforce of over 23,000 employees in more than 30 countries and regions, Grifols operates the largest network of plasma donation centers globally, spanning North America, Europe, Africa, the Middle East, and China. The company focuses on treating conditions across immunology, infectious diseases, pulmonology, critical care, hepatology, hematology, and neurology. As a recognized leader in transfusion medicine, Grifols offers a comprehensive portfolio of solutions designed to enhance safety from donation to transfusion, clinical diagnostic technologies, and biological supplies for life-science research and pharmaceutical manufacturing.